Skip to main content
  • Login
  • Contact
  • Subscriptions

Search form

Home

Deer Park Tribune

Deer Park weather

  • Home
  • News
  • Sports
  • Obituaries
  • Entertainment
    • Special Sections
    • Talking About...
  • Photos
  • Videos
  • Classifieds
    • Classified Display Ads
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
US Markets
  • Top Stories
  • Benzinga
  • GoldStocks.com
  • InvestorPlace
  • Marijuana Stocks
  • Motley Fool
  • PennyStocks.com
  • StockMarket.com
  • Syndication Cloud
  • TalkMarkets
Press Releases
  • 24-7 Press Release
  • 3BL Media
  • ABNewswire
  • AccessWire
  • BusinessWire
  • GlobeNewswire
  • iCrowdNewswire
  • Marketwired
  • New Media Wire
  • News Direct
  • Newswire.com
  • Online PR Media
  • PR.com
  • PR Leap
  • PR NewsWire
  • PRLog
  • PRWeb
  • ReleaseWire Direct
  • Send2Press
  • StatePoint Media
  • TheNewswire.com
  • WiredPRNews
Topics
  • Business & Finance
  • Health
  • Home & Garden
  • Lifestyle
Companies
  • Earnings
  • Upgrades & Downgrades
  • Mergers & Acquisitions
  • IPOs
  • Private Equity & Hedge Funds
  • Venture Capital
Sectors
  • Basic Materials
  • Conglomerates
  • Consumer Goods
  • Financial
  • Healthcare
  • Industrial Goods
  • Services
  • Technology
  • Utilities

BusinessWire

< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Greenwich LifeSciences Presents Immune Response Phase IIb Poster, Published Today at AACR 2021, Showing Peak Immunity after 6 Months of GP2 Treatment, Resulting in 100% Disease Free Survival from Recu
April 10, 2021
Tickers GLSI
From Business Wire News Releases
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Champignon Brands Inc. Investors – SHRMF
April 10, 2021
Tickers SHRMF
From Business Wire News Releases
AHF Welcomes Biden’s Proposed 15% HUD Budget Increase
April 10, 2021
From Business Wire News Releases
Positive Findings From Phase 1b Trial of GlycoMimetics’ GMI-1359 To Be Presented at AACR 2021 Meeting
April 10, 2021
Tickers GLYC
From Business Wire News Releases
GlycoMimetics to Present at AACR 2021 Meeting on Positive Therapeutic Effects of GMI-1757 in a Pancreatic Adenocarcinoma Model
April 10, 2021
Tickers GLYC
From Business Wire News Releases
Ultimovacs Presents the INITIUM Study Design as a Trial-in-Progress Poster at AACR Annual Meeting 2021
April 10, 2021
Tickers ULTI
From Business Wire News Releases
Data at AACR Demonstrate Growing Clinical Utility of Guardant Health Liquid Biopsies in the Treatment and Management of Advanced Cancers
April 10, 2021
Tickers GH
From Business Wire News Releases
Arcus Biosciences Presents Updated Data for Etrumadenant in Third-Line Metastatic Colorectal Cancer and New Data on its HIF-2α Program at the AACR 2021 Annual Meeting
April 10, 2021
Tickers RCUS
From Business Wire News Releases
Investigational Combination of Aliqopa® (copanlisib) and rituximab Significantly Increases Progression-Free Survival in Patients with Relapsed Indolent non-Hodgkin's Lymphoma
April 10, 2021
From Business Wire News Releases
Synthekine Presents Data at AACR Annual Meeting 2021 Demonstrating Selective IL-2 Partial Agonist, STK-012, Promotes Anti-Tumor Response without Related Toxicities
April 10, 2021
From Business Wire News Releases
Immune-Onc Therapeutics Announces First Public Presentation of Data for its Myeloid Checkpoint Inhibitor, IO-202, in Solid Tumors at AACR21
April 10, 2021
From Business Wire News Releases
Bicycle Therapeutics Announces Presentations at the AACR Annual Meeting 2021
April 10, 2021
Tickers BCYC
From Business Wire News Releases
ImmunoGen Presents Preclinical Data on IMGC936 at the AACR Virtual Annual Meeting
April 10, 2021
Tickers IMGN
From Business Wire News Releases
ITM Presents Design for Ongoing Phase III COMPETE Trial with n.c.a. 177Lu-Edotreotide at AACR Annual Meeting 2021
April 10, 2021
From Business Wire News Releases
Neoadjuvant Opdivo (nivolumab) Plus Chemotherapy Significantly Improves Pathologic Complete Response in Patients with Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial
April 10, 2021
Tickers BMY
From Business Wire News Releases
Tachyon Presents Promising Preclinical Data on Its First-in-class Pan-KDM4 Epigenetic Regulator, TACH101
April 10, 2021
From Business Wire News Releases
Scholar Rock Presents Biomarker Strategy to Support the SRK-181 DRAGON Phase 1 Proof-of-Concept Trial at the American Association for Cancer Research Annual Meeting
April 10, 2021
Tickers SRRK
From Business Wire News Releases
Spectrum Pharmaceuticals Presents Additional Twice Daily Dosing Data for Poziotinib at the AACR Virtual Meeting 2021
April 10, 2021
Tickers SPPI
From Business Wire News Releases
Xencor Presents Data from Multiple Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the AACR Annual Meeting 2021
April 10, 2021
Tickers XNCR
From Business Wire News Releases
Biodesix Releases New Data at AACR on Proteomic Profiling to Help Guide Physician Treatment Strategies for NSCLC Patients
April 10, 2021
Tickers BDSX
From Business Wire News Releases
SQZ Biotech Presents Preclinical Data on its mRNA-based enhanced APCs and the Potential of the SQZ APC Platform in KRAS Driven Tumors
April 10, 2021
Tickers SQZ
From Business Wire News Releases
Clovis Oncology Highlights Rubraca® (rucaparib) Clinical Data at AACR Virtual Annual Meeting 2021
April 10, 2021
Tickers CLVS
From Business Wire News Releases
Boundless Bio Presents Data on the Role of Extrachromosomal DNA (ecDNA) in Mediating Resistance to Targeted Therapies at the American Association for Cancer Research (AACR) Annual Meeting 2021
April 10, 2021
From Business Wire News Releases
Zymeworks Showcases Preclinical Assets, Including New Therapeutic Platform, ProTECT™, and Zanidatamab Mechanisms of Action at AACR Annual Meeting
April 10, 2021
Tickers ZYME
From Business Wire News Releases
Kezar Life Sciences Presents Preclinical Data with IND Candidate KZR-261 at American Association for Cancer Research (AACR) 2021 Virtual Annual Meeting
April 10, 2021
Tickers KZR
From Business Wire News Releases
Freenome Presents Data Revealing Signatures of Immune Checkpoint Inhibitor Treatment Response Found to Be Common Across Kidney, Melanoma, and Lung Cancers
April 10, 2021
From Business Wire News Releases
OncoMyx Presents at AACR First Data Showing Multi-Armed Myxoma Virotherapy Can Modulate Anti-Tumor Immune Response
April 10, 2021
From Business Wire News Releases
Tallac Therapeutics Presents New Data on Toll-like Receptor Agonist Antibody Conjugate, TAC-001, at the 2021 Virtual Annual Meeting of the American Association for Cancer Research (AACR)
April 10, 2021
From Business Wire News Releases
SORRENTO INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sorrento Therapeutics, Inc. - SRNE
April 09, 2021
Tickers SRNE
From Business Wire News Releases
INOVIO INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inovio Pharmaceuticals Inc. - INO
April 09, 2021
Tickers INO
From Business Wire News Releases
< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2020 The Deer Park Tribune | 104 N. Main Street | Deer Park, WA 99006 | (509) 276-5043
All property rights for the entire contents of this publication shall be the property of The Deer Park Tribune.
No part hereof may be reproduced without prior written consent.
Privacy and Terms of Use


Site Design, Programming & Development by Surf New Media